SOFIE Biosciences develops and manufactures radiopharmaceuticals for molecular imaging and theranostic applications. Founded in 2006, the company combines a radiopharmacy production and distribution network with contract manufacturing and the development of FAPI diagnostic compounds. Its radiopharmacy sites produce and deliver imaging agents across the United States, while its contract manufacturing work supports research, clinical trials, and commercial supply.
GMP Certified
21 CFR 211 and 212 cGMP standards
Compliance program
GMP
Quality certification
21CFR212
Quality certification
PharmaLogicPharmaLogic develops and manufactures diagnostic and therapeutic radiopharmaceuticals, while operating an integrated radiopharmacy and supply-chain platform. It evolved from a network of radiopharmacies built through strategic acquisitions into a global platform that supports drug development and commercialization. Its infrastructure includes 17 manufacturing sites worldwide and serves sponsors seeking clinical and commercial production.BARBOURSVILLE, WV
PharmaLogicPharmaLogic grew from a network of radiopharmacies in secondary and tertiary markets into a globally integrated radiopharmaceutical company serving sponsors and patients worldwide. Its infrastructure supports the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, with operations spanning 17 manufacturing sites and distribution to more than 30 countries.SAYRE, PA
Antelope Surgical Solutions, IncFounded in 2020, New York City-based Antelope Surgical Solutions develops small-molecule radiopharmaceuticals that help identify and treat cancer, including agents designed to make tumors glow during surgery. The pre-revenue, clinical-stage company operates a GMP manufacturing facility with robotic high-throughput synthesis and has received FDA IND clearance for its lead agent, AS1986NS.NEW YORK, NY
Molecular Targeting Technologies, IncMolecular Targeting Technologies, Inc. develops targeted radiopharmaceuticals and molecular-imaging technologies for cancer and other diseases, alongside research reagents such as CellVue® and NeuroVue® fluorescent dyes. Based in West Chester, Pennsylvania, the company’s work spans clinical-stage platforms including EBTATE® and EvaThera, as well as custom affinity absorbents and laboratory products. Its leadership brings extensive experience in radiopharmaceutical development, nuclear medicine, fluorescent chemistry, and biopharmaceutical regulation.325412WEST CHESTER, PA